NCT07709858 CHATEAU Registry: Clinical Outcomes After Transcatheter Aortic Valve Replacement
| NCT ID | NCT07709858 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Eunpyeong St. Mary's Hospital |
| Condition | Aortic Valve Stenosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2021-01-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2021-01-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a multicenter, retrospective registry study using the CHATEAU Registry. The study will evaluate patients who underwent transcatheter aortic valve replacement between January 2021 and December 2025. The purpose of the study is to assess clinical outcomes and valve performance after TAVR in real-world practice, with a focus on procedural strategies, valve-related factors, and long-term outcomes. Patient clinical information, imaging findings, procedural data, echocardiographic results, and follow-up outcomes will be collected from existing medical records. No additional intervention, treatment, or study-specific visit will be performed.
Eligibility Criteria
Inclusion Criteria: * Adults (≥18 years of age). * Patients who underwent transcatheter aortic valve replacement (TAVR) for severe native aortic valve disease at participating centers. * TAVR performed between January 1, 2021 and December 31, 2025. * Availability of baseline procedural and follow-up clinical data in the institutional registry or medical records. Exclusion Criteria: * Patients with insufficient clinical or procedural data for outcome assessment.
Contact & Investigator
Osung Kwon, MD, PhD
PRINCIPAL INVESTIGATOR
The Catholic University of Korea Eunpyeong St. Mary's Hospital
Frequently Asked Questions
Who can join the NCT07709858 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Aortic Valve Stenosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07709858 currently recruiting?
Yes, NCT07709858 is actively recruiting participants. Contact the research team at oscaesar@gmail.com for enrollment information.
Where is the NCT07709858 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT07709858 clinical trial?
NCT07709858 is sponsored by Eunpyeong St. Mary's Hospital. The principal investigator is Osung Kwon, MD, PhD at The Catholic University of Korea Eunpyeong St. Mary's Hospital. The trial plans to enroll 4,000 participants.